Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05160506 · ClinicalTrials.gov registry record · Phase 2
Corticosteroids to Treat Pancreatitis
A Phase 2 study of Pancreatitis and Pancreatitis, Acute, sponsored by Beth Israel Deaconess Medical Center.
- Recruiting
- Registry status
- Phase 2
- Development phase
- 86
- Enrollment target
- 1
- Study location
NCT05160506 is a Phase 2 study of Pancreatitis and Pancreatitis, Acute that is actively recruiting participants, run by Beth Israel Deaconess Medical Center. The registered enrollment target is 86 participants, below the 617-participant average among 17 other Pancreatitis trials with a reported enrollment target (86% lower). The trial reports 1 study location across 1 state.
The verdict
NCT05160506, a Phase 2 study of Pancreatitis and Pancreatitis, Acute, is actively recruiting participants, sponsored by Beth Israel Deaconess Medical Center.
- RECRUITING
- Registry status
- Phase 2
- Development phase
- 86 participants
- Enrollment target
- 1
- Study location
Study Summary
This research is being done to determine if the administration of a short course of intravenous hydrocortisone, an anti-inflammatory medication, to patients with severe acute pancreatitis will improve their clinical outcomes and decrease the length of hospitalization. We think that because inflammation in the body drives the progression of pancreatitis, giving a short course of intravenous hydrocortisone may mitigate disease progression and improve clinical outcomes in patients with severe acute pancreatitis.
Conditions Studied
Interventions
- DRUG Placebo
- DRUG Hydrocortisone
Study Locations (1)
Massachusetts
- Beth Israel Deaconess Medical Center - Boston
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 86 participants |
| Start Date | 2022-03-06 |
| Est. Completion | 2027-04 |
| Phase | Phase 2 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT05160506
The ClinicalTrials.gov registry entry for NCT05160506 describes a study currently listed as recruiting, categorized as Phase 2. The registered enrollment target is 86 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 617-participant average among 17 other Pancreatitis trials with a reported enrollment target (86% lower). The listed sponsor is Beth Israel Deaconess Medical Center, which has 488 total studies on file at ClinicalTrials.gov.
The record links to 4 conditions, with Pancreatitis appearing as the primary indexed condition, and to 2 interventions - of which Placebo is the first listed.
NCT05160506 reports 1 study location spanning 1 distinct geographic area - top geographies include Massachusetts.
Frequently Asked Questions
What is clinical trial NCT05160506 about?
NCT05160506 is a clinical study titled "Corticosteroids to Treat Pancreatitis". This research is being done to determine if the administration of a short course of intravenous hydrocortisone, an anti-inflammatory medication, to patients with severe acute pancreatitis will improve their clinical outcomes and decrease the length of hospitalization. We think that because inflammat...
What is the current status of trial NCT05160506?
This trial is currently recruiting. It is a Phase 2 study. The enrollment target is 86 participants. The study started on 2022-03-06. Estimated completion is 2027-04.
What conditions does trial NCT05160506 study?
This clinical trial studies the following conditions: Pancreatitis, Pancreatitis, Acute, Corticosteroid, Hydrocortisone.
What interventions are being tested in trial NCT05160506?
The interventions under investigation include: Placebo (DRUG), Hydrocortisone (DRUG).
Who is sponsoring clinical trial NCT05160506?
This trial is sponsored by Beth Israel Deaconess Medical Center, which has 488 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT05160506 being conducted?
This trial has 1 study location across Massachusetts. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Pancreatitis
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
Prospective Evaluation of Chronic Pancreatitis for Epidemiologic and Translational Studies
RECRUITING
-
Building and Sustaining Exercise Habits for Adults With Type 1 Diabetes
RECRUITING · NA
-
Scrambler Therapy in Chronic Pancreatitis
RECRUITING · NA
-
PROMs After Pancreatectomy
RECRUITING
-
Pancreas Registry and High Risk Registry
RECRUITING
-
A Study of Blood Based Biomarkers for Pancreas Adenocarcinoma
RECRUITING
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.